Want to see KURA full AI Analyst Report?
Kura Oncology (KURA) Ownership - Who Owns Kura Oncology?
Kura Oncology (KURA) Ownership Overview
- 2.45% Insiders
- 11.41% Mutual Funds
- 1.57% Other Institutional Investors
- 16.67% ETFs
- 67.89% Public Companies and Individual Investors
The ownership structure of Kura Oncology (KURA) stock is a mix of institutional, retail, and individual investors. Approximately 29.66% of the company’s stock is owned by Institutional Investors, 2.45% is owned by Insiders, and 67.89% is owned by Public Companies and Individual Investors.
The ownership structure of Kura Oncology (KURA) stock is a mix of institutional, retail, and individual investors. Approximately 29.66% of the company’s stock is owned by Institutional Investors, 2.45% is owned by Insiders, and 67.89% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Sep 28, 2026 | Kathleen Ford | $72,444 | |
| Sep 28, 2026 | Teresa Brophy Bair | $88,557 | |
| Sep 28, 2026 | Mollie Leoni | $130,580 | |
| Sep 28, 2026 | Brian T. Powl | $94,620 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Jun 30, 2026 | $115,286,286 | ||
| Jun 30, 2026 | Fisher Asset Management Llc | $6,866,518 | |
| Jun 30, 2026 | Royce & Associates Llc | $6,691,535 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| BlackRock, Inc. | 10,509,233 | Institution | 11.81% | 107,824,731 |
| Vanguard | 4,629,778 | Institution | 5.20% | 47,501,522 |
| Ishares | 4,615,780 | Institution | 5.19% | 47,357,903 |
| Vanguard Index Funds | 3,826,281 | Institution | 4.30% | 39,257,643 |
| Spdr | 2,938,662 | Institution | 3.30% | 30,150,672 |
| Troy Edward Wilson | 1,214,650 | Insider | 1.37% | 12,462,309 |
| Fidelity Salem Street Trust | 1,022,335 | Institution | 1.15% | 10,489,157 |
| Fidelity Concord Street Trust | 884,005 | Institution | 0.99% | 9,069,891 |
| Blackrock Funds | 653,639 | Institution | 0.73% | 6,706,336 |
| Fidelity | 633,237 | Institution | 0.71% | 6,497,012 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 3,826,281 | Institution | 4.30% | 39,257,643 |
| Fidelity Salem Street Trust | 1,022,335 | Institution | 1.15% | 10,489,157 |
| Fidelity Concord Street Trust | 884,005 | Institution | 0.99% | 9,069,891 |
| Blackrock Funds | 653,639 | Institution | 0.73% | 6,706,336 |
| Dfa Investment Dimensions Group Inc | 592,987 | Institution | 0.67% | 6,084,047 |
| Vanguard Scottsdale Funds | 588,069 | Institution | 0.66% | 6,033,588 |
| Tiaa-cref Funds | 301,598 | Institution | 0.34% | 3,094,395 |
| Vanguard Horizon Funds | 300,321 | Institution | 0.34% | 3,081,293 |
| Vanguard Explorer Fund | 245,051 | Institution | 0.28% | 2,514,223 |
| Exchange Place Advisors Trust | 240,434 | Institution | 0.27% | 2,466,853 |
Top ETF Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard, VTI ETF | 2,799,338 | Institution | 3.15% | 29,980,910 |
| SPDR, XBI ETF | 2,655,810 | Institution | 2.99% | 28,045,354 |
| iShares, IWM ETF | 2,149,330 | Institution | 2.42% | 22,696,925 |
| Vanguard, VXF ETF | 1,012,406 | Institution | 1.14% | 10,842,868 |
| iShares, IWO ETF | 799,360 | Institution | 0.90% | 8,201,434 |
| iShares, IBB ETF | 679,086 | Institution | 0.76% | 6,967,422 |
| Fidelity, FESM ETF | 540,010 | Institution | 0.61% | 5,702,506 |
| Vanguard, VTWO ETF | 495,369 | Institution | 0.56% | 5,305,402 |
| Schwab, SCHA ETF | 474,781 | Institution | 0.53% | 5,013,687 |
| iShares, IDNA ETF | 248,068 | Institution | 0.28% | 2,545,178 |
FAQ
Who Owns Kura Oncology (KURA)?
According to the latest TipRanks data, approximately 29.66% of the company's stock is held by institutional investors, 2.45% is held by insiders, and 67.89% is held by public companies and individual investors.
What percentage of Kura Oncology (KURA) stock is held by institutional investors?
According to the latest TipRanks data, approximately 29.66% of Kura Oncology (KURA) stock is held by institutional investors: 11.41% by mutual funds, 16.67% by ETFs and 1.57% by other institutional investors.
What percentage of Kura Oncology (KURA) stock is held by retail investors?
According to the latest TipRanks data, approximately 67.89% of Kura Oncology (KURA) stock is held by public companies and individual investors.
Who owns the most shares of Kura Oncology (KURA)?
BlackRock, Inc. owns the most shares of Kura Oncology (KURA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
